EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

mRNA Vaccine Against Japanese Encephalitis Virus Genotype IV Protects Against Lethal Infection

Abigail L Cox iD, Wilson Nguyen iD, Lucy Wales-Earl iD, Bing Tang, Kexin Yan, Jonathan Peters, Alexander A Khromykh, Romain Tropée, Nigel A J McMillan, Andreas Suhrbier, Daniel J Rawle

Viruses · 28.01.2026 · 18 (2) · 171

DOI: 10.3390/v18020171 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, online erschienen am 28.01.2026. Verfasst von Abigail L Cox und 10 weiteren Autor:innen. Beteiligte Einrichtung: Infection and Inflammation Department, QIMR Berghofer, Brisbane, QLD 4029, Australia. Hauptthemen laut MEDLINE: Encephalitis, Japanese, Encephalitis Virus, Japanese, Japanese Encephalitis Vaccines, mRNA Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MRFF (Department of Industry, Science, Energy and Resources), Brazil Family Foundation, National Health and Medical Research Council (Australia).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In 2022, Australia saw an unprecedented outbreak of Japanese encephalitis virus genotype IV (JEV GIV). The outbreak involved 42 human cases with 7 fatalities, as well as affecting >80 pig farms in New South Wales and Queensland. Herein, we designed, constructed, and tested two JEV GIV mRNA vaccines encoding prME, which provided protection against a lethal JEV GIV challenge in an Ifnar-/- mouse model. The vaccines were not codon optimized and included either the Native (full-length) or a Shorter signal peptide, with the latter missing the N-terminal n-region. Two vaccinations with 5 µg of the Shorter vaccine provided neutralizing antibody responses that were significantly lower but overlapped with those seen after vaccination with Imojev, a live attenuated vaccine approved for use in humans. Both mRNA vaccines provided approximately a five to six log reduction in viremia, ≥80% protection against overt disease and weight loss, and mortality. The paper illustrates in-country mRNA vaccine generation in response to a local outbreak, with JEV mRNA vaccines potentially emerging to be easier to manufacture, cheaper, and more suitable for immunocompromised individuals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Encephalitis, JapaneseEncephalitis Virus, JapaneseJapanese Encephalitis VaccinesmRNA VaccinesAnimalsGenotypeAntibodies, NeutralizingMiceAntibodies, ViralFemaleDisease Models, AnimalHumansVaccines, AttenuatedVaccinationMice, KnockoutVaccines, Synthetic

Stichwörter der Autor:innen

Ifnar-/- miceJapanese encephalitis virusgenotype IVmRNA vaccine

Substanzen

Antibodies, NeutralizingJapanese Encephalitis VaccinesAntibodies, ViralmRNA VaccinesVaccines, AttenuatedVaccines, Synthetic

Autor:innen und Institutionen

  • Infection and Inflammation Department, QIMR Berghofer, Brisbane, QLD 4029, Australia.
  • Faculty of Health, Medicine and Behavioural Sciences, University of Queensland, St. Lucia, QLD 4072, Australia.
  • Nanomedicine Biofoundry, Institute for Biomedicine and Glycomics, Griffith University, Southport, QLD 4215, Australia.
  • Southern RNA Pty Ltd., 16 Nexus Way, Southport, QLD 4215, Australia.
  • School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, QLD 4072, Australia.
  • GVN Center of Excellence, Australian Infectious Disease Research Centre, Brisbane, QLD 4029 and 4072, Australia.

ORCID-Profile: Abigail L Cox, Wilson Nguyen, Lucy Wales-Earl

Förderung

  • MRFF (Department of Industry, Science, Energy and Resources)
  • Brazil Family Foundation
  • National Health and Medical Research Council (Australia)
  • University of Queensland
  • National Health and Medical Research Council (NHMRC) of Australia

Zitieren

APA

Cox, A. L., Nguyen, W., Wales-Earl, L., Tang, B., Yan, K., Peters, J., Khromykh, A. A., Tropée, R., McMillan, N. A. J., Suhrbier, A., & Rawle, D. J. (2026). mRNA Vaccine Against Japanese Encephalitis Virus Genotype IV Protects Against Lethal Infection. Viruses, 18(2), 171. https://doi.org/10.3390/v18020171

Vancouver

Cox AL, Nguyen W, Wales-Earl L, Tang B, Yan K, Peters J, et al. mRNA Vaccine Against Japanese Encephalitis Virus Genotype IV Protects Against Lethal Infection. Viruses. 2026;18(2):171. doi:10.3390/v18020171

BibTeX
@article{Cox2026,
  author = {Cox, Abigail L and Nguyen, Wilson and Wales-Earl, Lucy and Tang, Bing and Yan, Kexin and Peters, Jonathan and Khromykh, Alexander A and Tropée, Romain and McMillan, Nigel A J and Suhrbier, Andreas and Rawle, Daniel J},
  title = {mRNA Vaccine Against Japanese Encephalitis Virus Genotype IV Protects Against Lethal Infection},
  journal = {Viruses},
  year = {2026},
  volume = {18},
  number = {2},
  pages = {171},
  doi = {10.3390/v18020171}
}
Kostenlos starten →